> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Imaging Drugs Panel to Review NX Development Imaging Agent
- URL: https://www.fdaweb.com/imaging-drugs-panel-to-review-nx-development-imaging-agent/
- Published: 2017-04-19T12:00:00.000Z
- Updated: 2026-09-14T22:18:29.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138488

*Federal Register* notice: FDA has announced a 5/10 Medical Imaging Drugs Advisory Committee meeting that will discuss a NX Development Corp. NDA for 5-aminolevulinic acid hydrochloride for the proposed indication as an imaging agent to assist in real time detection and visualization of malignant tissue during glioma surgery. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-04-18/pdf/2017-07767.pdf?ref=fdaweb.com).